Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley
|
|
- Ethelbert Davis
- 6 years ago
- Views:
Transcription
1 Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley
2
3
4
5 Approximately 45% of AVF are functional without intervention after creation The procedure rate is procedures/avf required for maturation 1.7 procedures/access/year Once matured- revision rate range from 0.17 to 0.57 and is required in 50% of AVF
6 Long term patency AVF- prevent and correct thrombosis Ability to predict presence of stenosis prospectively Physical examination U/S Transonic flow measurements Physiological disturbances during dialysis PTA is safe, easily performed and effective Seminars in Dialysis 2004;17,
7
8
9
10
11 Access Progression from creation to interventional maintenance Referral to renal unit Identified CKD Nephrologists CKD NP Pre Dialysis Nurse Referral to Access Nurse Ultrasound for optimal access placement Access Creation Start dialysis Investigation of low flows Ultrasound or Fistula gram Follow up post O.T. by Access Nurse Vascular access clinic Ultrasound fistula Mapping Regular Flow monitoring Intervention as indicated angioplasty / stent Ongoing Survalence
12
13 Retrospective review January, 2006 and July, 2009 in a single centre 100 haemodialysis patients with dysfunctional arteriovenous access 187 consecutive percutaneous vascular procedures
14 Decreased or absent thrill Prolonged bleeding time post dialysis Increased dynamic venous pressures x 3 occasions Decreased arterial flow < 500ml/min ( transonic) Reduction of flow below 25% of base line Recirculation
15
16
17
18 First PTA Second PTA 1yr 18 months 47% Primary patency rates at 6, 12, and 18 months were 72%, 55% and 47% respectively
19 1 2 Thrombosis 3 90% 18 months Secondary patency rates at 6, 12, and 18 months were 96%, 93% and 90% respectively Mean cumulative patency was 36.8 months ± SE 1.27(95% CIs )
20 Pre and post access flow studies
21 Clinical success: 93% (172 of 184 interventions) and Anatomic success: 91% (169 of 184 interventions) Complication rate was 5.9% Major complication leading to access loss occurred in one patient (0.5%).
22 Impact of vascular access programme Thrombosis rates AVF redo rates Vs primary AVF creation ( use of surgical time) Bacteraemia rates in prevalent dialysis population Procedural cost
23 135 patients in 2008 (historical control) and 125 patients in 2009 (5 grafts) Graft AVF Total TQa < 500ml/min or reduction by >25% in three months AVF episodes per patient year at risk AVG Overall (50%) NEPHROLOGY 2010; 15 (SUPPL. 4)
24 Retrospective analysis of all surgical procedures by a single vascular surgeon Jan 2002 March 2010 Time Period Total Surgery AVF Formations AVF Total Surgery Revisions and related procedures Dialysis Population Jan 2002 to May 2005 (no formal organization) May 2005 to December 2005 (OT only) January 2006 to September 2006 (OT and EVR) September 2006 to December 2008 (OT,EVR and SC) January 2009 to March 2010 (OT,EVR, SC and VAN) NEPHROLOGY 2010; 15 (SUPPL. 4)
25 Population Fisher Exact Test p = Population Fisher Exact test p= NEPHROLOGY 2010; 15 (SUPPL. 4)
26 Temporary Access Related Bacteraemia and Patient Catheter Days Patient Catheter Days(1/100 scale) Infection Number Bacteraemic episodes 16 4 p=0.001 Patient Catheter Days p= Infections/1000 Days p=0.40 NEPHROLOGY 2010; 15 (SUPPL. 4)
27 Temporary Access Related Bacteraemia and Interventional procedures, Interventional Nephrologist Number, and Vascular Access Surveillance Program with Dedicated Nurse Fistuloplasties(1/2 scale) Infection Number Nephrologist Number Access Surveillance Program with dedicated Nurse
28
29
30 SCENARIO 1: Peripheral Angioplasty SCENARIO 2: Surgical Repair of AV Fistula SCENARIO 3: Surgical Creation of AV Fistula Prosthetic DRG AR-DRG Low Trim High Trim Extra High Cost (Incl Inlier Short Stay Long Stay Extra Long MDC Type Description Cost ALOS 5 Point Point Trim Point in DRG) Allocation per Day per Day Stay per Weight ($) ($) ($) ($) Day ($) F14C 5 S VASC PR-MJR RECONSTR-PUMP-CSCC $64 $5,783 $5,783 $982 $358 F21B 5 S OTH CIRC SYS O.R. PR -CCC $46 $7,732 $7,732 $982 $358 Z01B 23 S OR PR+DX OTH CNT HLTH SRV-CSCC $62 $2,809 $2,809 $982 $358
31 Thrombolysis + Angioplasty Repeat plasty + stent [Unit cost] $1,200 $3,300 [Unit cost] 13 x 1,200 = $15,600 2 x $3,300 = $6,600 Total cost $22,200, At the time of termination of study, duration of patency range 1-37 months. 3 Cases of fistula demise 12, 18, 19 months. None required catheter bridge. Surgical Thrombectomy/ revision- 13x7732 = $ 100,516 Cost of Catheter bridge $???
32 Conclusion An optimal outcome is likely when there is: Multidisciplinary team approach Consensus about goals among interested parties Restriction of access to interested and experienced surgeons Routine pre operative mapping and post operative surveillance and intervention Prospective tracking of outcomes with continuous quality assessment Immediate benefits include: Continuation of Dialysis Avoidance of temporary catheters Avoidance of access abandonment (In some cases) Provides increased surgical time for primary AVF creation
Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance
Hemodialysis Access Surveillance Postoperative AV Fistula Evaluation Failure of maturation Stenosis Perigraft mass/fluid collection Joseph L. Mills, Sr., M.D. Professor of Surgery Chief, Division of Vascular
More informationMedical Director/Surgeon as Partners WebEx February 11, 2010
Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances
More informationUPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC
UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC Background Endovascular AVF Outline Data from FLEX and NEAT study SPH data Clinical experience Cannulation
More informationSupera for the Juxta-anastomotic AVF Stenosis
Supera for the Juxta-anastomotic AVF Stenosis Dr Shannon D. Thomas Vascular Access Surgeon Conjoint Senior Lecturer University of New South Wales Sydney, Australia Disclosure Speaker name: Dr S. D. Thomas...
More informationWhy Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF
Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate
More informationIN ARTERIOVENOUS FISTULA FAILURE
DRUG ELUTING BALLOON ANGIOPLASTY IN ARTERIOVENOUS FISTULA FAILURE Nicola Troisi, MD GUIDELINES GUIDELINES VAS 2007 GUIDELINES VAS 2007 GUIDELINES VAS 2007 GUIDELINES VAS 2007 2007!!!!!!!!!! GUIDELINES
More informationVascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?
Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier? Plan the Work Work the Plan What is a plan? A method for achieving an end An orderly arrangement of parts
More informationJuxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?
Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Richard Shoenfeld MD, FSIR, FAHA The Access Center at West Orange West Orange, New Jersey USA SEDAV 2015 Madrid November
More informationCATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care
CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your
More informationPercutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience
Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Poster No.: C-3355 Congress: ECR 2010 Type: Scientific Exhibit Topic: Interventional
More informationJVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE
JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,
More informationDecreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program
Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients
More information( GFR 30 ml/min/1.73m 2 ) [2] (Tunneled cuffed catheter) [1] [3]
[1] 07-3422121-2045 E-mail: cyhsu@vghks.gov.tw ( GFR 30 ml/min/1.73m 2 ) [2] (fistula) (graft) (Tunneled cuffed catheter) [3] 97 20 2 63 Allen s test (Duplex doppler ultrasound) [4] 2.0 mm2.5 mm [5] ()
More informationRenal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)
More informationIntroduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents
Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce
More informationVascular access. The KidneyCare Audit
Vascular access The KidneyCare Audit Renal National Service Framework The challenge of vascular access Standard 3 All children, young people and adults with established renal failure are to have timely
More informationASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS
DISCLOSURES UTILITY OF ULTRASOUND IN EVALUATING ACCESS DYSFUNCTION None Vandana Dua Niyyar, MD Assistant Professor of Medicine, Division of Nephrology, Emory University UTILITY OF ULTRASOUND IN ACCESS
More informationPreservation of Veins and Timing for Vascular Access
Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access
More informationTechnical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University
More informationGuidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter
Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter The guidelines for arteriovenous access intervention, management and abandonment,
More informationQizhuang Jin. Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China
Safety and Efficacy of the Paclitaxel Releasing Peripheral Balloon Dilatation Catheter (APERTO OTW ) for Arteriovenous Fistulae Stenosis: a Prospective, Multicenter, Randomized Controlled Trial APERTO
More informationASDIN 7th Annual Scientific Meeting
Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of
More informationPercutaneous AV Fistula Creation. Ellipsys EndoAVF System
Percutaneous AV Fistula Creation Ellipsys EndoAVF System Presented by Forest Rawls Jr CHT,CCHT-A,FNKF No Disclosures Various Access Types Some old Some new Scribner Shunt OUR OLD DEPENDABLE FRIEND
More informationGerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?
Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo,
More informationASDIN 8th Annual Scientific Meeting
Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure
More informationVascular a ccess access for Dialysis a surgeon s perspecti e v. some observations
Vascular access for Dialysis a surgeon s perspective e. some observations Age of New Haemodialysis Patients 2005 Australia Number (Total=1957) 0.7% 3% 5% 10% 15% 20% 26% 19% 2% 0-14 15-24 25-34 35-44
More informationFirst experience with DCB for treatment of dialysis access stenosis The Greek experience
First experience with DCB for treatment of dialysis access stenosis The Greek experience D Karnabatidis Department of Interventional Radiology Patras University Hospital Patras, Greece Background Vessel
More informationIN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators
IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following
More informationUC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next
No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -
More informationAMMAR SERAWAN, MD. Ain Wzain Hospital. April 21, 2012 Vascular Access Study Workshop
AMMAR SERAWAN, MD Ain Wzain Hospital April 21, 2012 Vascular Access Study Workshop 1 Inspection for signs of: - infection (redness, discharge, edema) -aneurysms (may be cannulated using the lateral side
More informationBalloon angioplasty for arteriovenous graft stenosis Anain P, Shenoy S, O'Brien M, Harris L M, Dryjski M
Balloon angioplasty for arteriovenous graft stenosis Anain P, Shenoy S, O'Brien M, Harris L M, Dryjski M Record Status This is a critical abstract of an economic evaluation that meets the criteria for
More informationIntroduction. Introduction 2/18/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life
Introduction Vascular Access complications: Ultrasound Evaluation of the Mature AVF and Process Improvement High associated morbi-mortality Worsened quality of life Up to 25 % hospitalized Jose Ibeas M.D.,
More information2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi
Stage 5 Chronic Kidney Disease Assessing the Results of AV Access: Realistic Outcomes in 2009 Sean P. Roddy, MD Albany, NY Defined as a GFR
More informationPhysician Clinical Experiences with FIR Therapy in the UK and Taiwan
ENGLAND 1. Source: Moore I 1, Adam JH, Sweeney D, et al. (2011). Far infrared (FIR) therapy An effective treatment for AV fistula maturation and maintenance. J Am Soc Nephrol 2011; 22: 564A (Poster FR-PO1947).
More informationOutcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients
Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients Nicholas Petruzzi, MD Raphael Cohen, MD Mark Mantell, MD Timothy W. Clark,
More informationRandomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis
Kidney International, Vol. 66 (2004), pp. 390 398 Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis LAURA M. DEMBER,ERIKA F. HOLMBERG, and JAMES S. KAUFMAN
More informationSid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face
Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National
More informationClinical Study Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis
International Vascular Medicine Volume 215, Article ID 97122, 7 pages http://dx.doi.org/1.1155/215/97122 Clinical Study Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis Brendon
More informationRegardless of whether you are a vascular surgeon,
C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless
More informationKDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium
DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.20.01 30.20 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationNursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN
Nursing Care of the Dialysis Patient Adrian Hordon, MSN, RN Understand principles of hemodialysis Recognize different access ports Identify side effects and complications Discuss nursing care for pre and
More informationSurgical Options in Thrombectomy for Non-Surgeons
Surgical Options in Thrombectomy for Non-Surgeons Shouwen Wang, MD, PhD, FASDIN AKDHC Ambulatory Surgery Center Arizona Kidney Disease and Hypertension Center Phoenix, Arizona Disclosure No relevant financial
More informationHemodialysis Fistula Maturation Consortium
Hemodialysis Fistula Maturation Consortium Rationale for Fistula Maturation Study Dialysis Access Consortium AVF study 60% of new AVFs were unusable for dialysis at 4-5 months post surgery No predictors
More informationVascular Access for Haemodialysis. Mike Stephens
Vascular Access for Haemodialysis Mike Stephens Overview Learning Objectives History and development of vascular access Standards in vascular access surgery Types of vascular access Complications Objectives
More informationPitfalls in pushing fistulas ----
Pitfalls in pushing fistulas ---- An argument for more grafts Marc Webb, MD, FACS Michigan Vascular Access, PC March 27 th, 2009 Vascular Access for Hemodialysis ------- Basic facts - the need for Access
More informationVascular Access Study Overview and Implementation
Vascular Access Study Overview and Implementation Salim Kabalan, MD Co-Principal Investigator Hafez Elzein, MD, MS Managing Director April 21, 2012 Investigator Meeting & Workshop Introduction Majority
More informationAssessment, Monitoring, and. Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008
Vascular Access Assessment, Monitoring, and Surveillance Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008 1 Special Acknowledgement for Content Contributions: RMS
More informationAccess Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares. Who am I? Disclosures
Access Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares Jason Burgess, MD RVT Surgical Specialists of Charlotte CMC-Mercy Charlotte, NC Disclosures Gore Vascular- Consultant
More informationPercutaneous and Surgical Treatments
AVG Pseudoaneurysms Percutaneous and Surgical Treatments Marius Florescu M.D. Feb. 2015 ASDIN DEFINITION AVG Pseudoaneurysm Formation Incidence AVG Pseudoaneurysm incidence rate ranges between 2% and 10%
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationDoppler Ultrasound: is it a third generation AVF surveillance method?
Doppler Ultrasound: is it a third generation AVF surveillance method? Jose Ibeas. Servei de Nefrologia Parc Tauli Sabadell, Hospital Universitari Barcelona Disclosures I have the following potential conflicts
More informationLutonix in AV fistula and Early look AV IDE trial data
Lutonix in AV fistula and Early look AV IDE trial data Jackie P Ho Dept of Cardiac, Thoracic & Vascular Surgery National University of Singapore NUHS, Singapore Lutonix in AV fistula and final AV IDE trial
More informationCurrent treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database
ORIGINAL ARTICLE Korean J Intern Med 218;33:116-1168 https://doi.org/1.394/kjim.218.17 Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health
More informationSichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital
Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Button hole or Ladder?? Vascular Access Cannulation It s a Life Line of Hemodialysis patient Arterio-venous fistula(avf) is the K/DOQI
More informationThoughtful vs. Dogmatic
Debate on Balloon Assisted Maturation The Biology is Wrong: BAM Won t Work BAM Dr. Rapp Debate BIVF Dr. Lawson Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical
More informationThe Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice
The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr
More informationHD Scanning: Velocities and Volume Flow
HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year
More informationLysis-Assisted Balloon (LAB) Thrombectomy
Lysis-Assisted Balloon (LAB) Thrombectomy Panagiotis M. Kitrou MD, MSc, PhD, EBIR Consultant Interventional Radiologist Interventional Radiology Dpt. Patras University Hospital Greece Facts & Figures Thrombosis:
More informationTechnical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand
Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB Andrew Holden Auckland Hospital Auckland, New Zealand LINC 2017 26 th January 2017 Disclosure Speaker name: Andrew Holden I have
More informationThe Renal Physicians Association Quality Improvement Registry
In collaboration with CECity The Renal Physicians Association Quality Improvement Registry This registry is approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Professionals and GPRO
More informationInterventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?
Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Martin Forlee Vascular Surgeon Cape Town Disclosure Speaker name: Martin Forlee I have the following potential conflicts of interest
More informationEvaluation of AVF and AVG
Evaluation of AVF and AVG 2013 Nephrology Nursing Symposium Albuquerque Vascular Access Leading cause of hospitalization in the ESRD population Annual cost approaching $1.5 billion (USRDS, 2004) Current
More informationASDIN 9th Annual Scientific Meeting
Stent Graft Placement is Best for Cephalic Arch and Central Vein Stenosis Dheeraj K. Rajan MD, FRCPC, FSIR Head - Division of Vascular and Interventional Radiology University of Toronto University Health
More informationTale of Neglected Aneurysm
Disclosures Tale of Neglected Aneurysm Consultant to FFCL Tushar Vachharajani, MD, FASN Chief, Nephrology Section Salisbury VAMC, NC Objectives How do you define Aneurysm? When and How do you treat? Defining
More informationSelection of Permanent Hemodialysis Vascular Access
Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements
More informationMechanical thrombectomy in acute thrombosis of dialysis fistulas: a multi-center study
Mechanical thrombectomy in acute thrombosis of dialysis fistulas: a multi-center study Clément Marcelin 1 Y Le Bras 1, MD, F. Petitpierre 1, MD, N. Grenier 1, MD PHD, J V D Berg MD PHD 3, B Huasen 2, MD
More informationCurrent Status of DCB Experience with Non- Femoropopliteal Applications (Dialysis, Tibial, Venous)
Current Status of DCB Experience with Non- Femoropopliteal Applications (Dialysis, Tibial, Venous) Saher Sabri, MD University of Virginia Health System Charlottesville, Virginia Dialysis vascular access
More informationMANITOBA RENAL PROGRAM
SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.30.01 30.30 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice
More informationFistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting
Fistula First "Unassisted" evaluation of access dysfunction (eyes, ears, and fingers) Tushar Vachharajani, MD Chief, Nephrology Section W. G. (Bill) Hefner VAMC Salisbury, NC Quality improvement projects
More informationCSI (Clinical Scenario Investigation): Hyperkalemia
CSI (Clinical Scenario Investigation): Hyperkalemia Alison Thomas, RN(EC), MN, CNeph(C) Ann Jones, RN(EC), MSN, CNeph(C) Joyce Hunter, RN, Vascular Access Co-ordinator Simcoe Muskoka Regional Kidney Care
More informationRenal Patient s Information Leaflet
Renal (Haemodialysis) Unit Patient Information Renal Patient s Information Leaflet Opening hours: If you need this information in large print, easy read, on audiotape or in another language please call
More informationThe Art of Angioplasty
The Art of Angioplasty Achieving and Defining Success Thomas M. Vesely, MD Saint Louis, Missouri Dr. Vesely is a consultant for: W.L. Gore & Associates Lutonix Imaging the Vascular Access Circuit A well
More informationRecurrent lesions in AV access & Initial DCB experience in India
Recurrent lesions in AV access & Initial DCB experience in India Dr. Virender K Sheorain Consultant Interventional Radiologist Medanta-The Medicity Hospital Gurgaon, INDIA Disclosure Speaker name:... I
More informationJimmy Wei Hwa Tan, Surg, MD
Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following
More informationPatient Information Having a Fistuloplasty or Venoplasty
Patient Information Having a Fistuloplasty or Venoplasty Renal Department Introduction This leaflet is intended to provide you with information about having a fistuloplasty. What is a fistuloplasty or
More informationHAEMODIALYSIS. Types of vascular access used for first haemodialysis 2012 to June 2016
SECTION H VASCULAR ACCESS FOR HAEMODIALYSIS Details of vascular access used for haemodialysis for all hospital and home haemodialysis patients were collected during the SRR census week in May 2016. The
More informationEnd Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity
End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity October 2, 2018 Note: Computer speakers or headphones are necessary
More informationIntroduction. Introduction 2/3/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life
Introduction Vascular Access complications: Ultrasound Evaluation of the Mature AVF and Process Improvement High associated morbi-mortality Worsened quality of life Up to 2 % hospitalized Jose Ibeas M.D.,
More informationSt George Hospital Renal Department Internal Policy
COMPLICATIONS OF VASCULAR ACCESS FOR HAEMODIALYSIS. SUMMARY: Any type of complication for either a centrally placed venous catheter or arterio-venous fistula/graft can place the patient at risk of sub-optimal
More informationScottish Haemodialysis Vascular Access Appraisal
Scottish Renal Registry Scottish Haemodialysis Vascular Access Appraisal Summary Document Scott W. Oliver, Jacqueline Campbell, David B. Kingsmore, Ram Kasthuri, Jamie Traynor, Wendy Metcalfe, Peter C.
More informationMIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai
MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa,
More informationVA Session: A Team-Based Approach to Solving Vascular Access Problems. October 7, 2016
2016 VA Session: A Team-Based Approach to Solving Vascular Access Problems October 7, 2016 Panel discussion with: Dr. Mercedeh Kiaii (nephrologist) Dr. Jerry Chen (surgeon) Mirita Zerr (vascular access
More informationNational Surveillance System for Dialysis Centre and Dialysis Associated Diseases
National Surveillance System for Dialysis Centre and Dialysis Associated Diseases Dr Richard Fluck Consultant Renal Physician & Clinical Director, Royal Derby Hospital UK RA Vascular Access Survey 2005
More informationProspective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access
Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts
More informationDeveloping a Quality Assurance Performance Improvement (QAPI) Program at Your Dialysis Center Rudolph P. Valentini, M.D. Associate Professor of Pediatrics Director of Dialysis Services Vice Chief of Staff
More informationDrug-eluting balloon for the treatment of failing hemodialytic arteriovenous fistulas
Drug-eluting balloon for the treatment of failing hemodialytic arteriovenous fistulas Poster No.: C-0216 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Exhibit M. B. Cilda#, K. Köseo#lu; Ayd#n/TR
More informationCase Endovascular management of non maturing dyalisis vascular access
Case 10238 Endovascular management of non maturing dyalisis vascular access Guedes Pinto 1, Erique; Madeira 2, Célia; Sousa 3, Marta; Penha 1, Diana; Rosa 1, Luís; Germano 1, Ana; Baptista 1, Manuela 1
More informationPeripheral Vascular Disease
Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of
More information*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD
The views presented reflect those of the author/presenter and do not necessarily reflect those of ASDIN nor serve as an endorsement of safety, efficacy or applicability of said procedure. the Endovascular
More informationWhat s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute
What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3
More informationExplorations fonctionnelles des abords vasculaires pour hémodialyse
Explorations fonctionnelles des abords vasculaires pour hémodialyse Frank Le Roy Nephrology Department Actualités Néphrologiques Jean Hamburger Necker, 27 avril 2015 1966 Brescia, Cimino, Appel, Hurwich.
More informationSt George Hospital Renal Department Internal Only
RENAL VASCULAR ACCESS CANNULATION POLICY AND PROCEDURE SUMMARY: A functioning arteriovenous fistula (AVF) or arteriovenous graft (AVG) is paramount in the maintenance of regular and optimal haemodialysis
More informationCase #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty
Unraveling the -59 modifier Principles of Interventional Coding Donald Schon, MD, FACP Debra Lawson, CPC, PCS Distinct or independent from other services performed on the same day Normally not reported
More informationAVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose
Local elastase to aid fistula maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2013 UCSF Vascular Symposium I have nothing to disclose AVF Prevalence 60.6% (April 2012) Fistula First Initiative
More informationPREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S
PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S THE INCREASE IN THE CONSTRUCTION OF AUTOGENOUS FISTULAE OVER THE PAST TEN YEARS HAS BROUGHT WITH IT 1.
More informationVascular Access Options for Apheresis Medicine
Vascular Access Options for Apheresis Medicine Josh King, MD Divisions of Nephrology and Medical Toxicology University of Virginia September 21, 2018 Disclosure I have no personal or professional financial
More informationCOVERA Vascular Covered Stents in the Management of Dysfunctional AV Access
COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of
More informationThrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)
Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Hospital Outpatient 2019 Edition All Reimbursement Amounts are Listed at ational Unadjusted Medicare Rates and Do ot Include the 2%
More information